Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026, Mar 2026, Apr 2026, Jun 2026, Jul 2026 and Sep 2026.
- Largest single sale: $5.1M (112,275 shares) of Mineralys Therapeutics, Inc. on Nov 11, 2025. Filing
- Last sale before this period: Oct 13, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Chief Executive Officer, Director | Feb 9, 2023 | Oct 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 30, 2026, Mineralys Therapeutics, Inc.: sold 75,000 shares for $1.9M, under a disclosed plan. 1 filing: 1
- Jul 13, 2026, Mineralys Therapeutics, Inc.: sold 10,700 shares for $291K, under a disclosed plan. 1 filing: 1
- Jun 30, 2026, Mineralys Therapeutics, Inc.: sold 75,000 shares for $2.0M, under a disclosed plan. 1 filing: 1
- Apr 13, 2026, Mineralys Therapeutics, Inc.: sold 15,730 shares for $422K, under a disclosed plan. 1 filing: 1
- Mar 31, 2026, Mineralys Therapeutics, Inc.: sold 75,000 shares for $2.0M, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.